4,5-dihydropyrazolo[3,4-a]acridin-1-amine
|
|
Descriptors Computed from Structure
Canonical SMILES:
C1CC2=NC3=CC=CC=C3C=C2C4=C1C=NN4N
Isomeric SMILES
C1CC2=NC3=CC=CC=C3C=C2C4=C1C=NN4N
InChI
InChI=1S/C14H12N4/c15-18-14-10(8-16-18)5-6-13-11(14)7-9-3-1-2-4-12(9)17-13/h1-4,7-8H,5-6,15H2
Other Product
- 2,5-bis(chloranyl)cyclohexa-2,5-diene-1,4-diol
- 2,5-bis(chloranyl)benzene-1,4-diol
- 2,5-bis(chloranyl)phenol
- 2-oxidanylidenehexanedioic acid
- 2-oxidanylidene-3-sulfanyl-propanoic acid
- 3-oxidanylbenzaldehyde
- 3-azanylpropanal
- 2-azanyl-3-oxidanyl-benzoic acid
- 3-(3-hydroxyphenyl)propanoic acid
- 3-oxidanylidenehexanedioic acid
- (2Z)-2-(dimethylaminomethylidene)-3,4-dihydroacridin-1-one
- ethyl 2-(4-methylphenyl)-5-oxidanylidene-1,2-oxazole-4-carboxylate
- ethyl (Z)-3-bromanyl-4,4,4-tris(fluoranyl)but-2-enoate
- ethyl (Z)-4,4,4-tris(chloranyl)-3-methoxy-but-2-enoate
- (4R)-4-[(3R,5R,8R,9S,10S,12S,13R,14S,17R)-10,13-dimethyl-3,12-bis(oxidanyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-N-[(E)-(phenylmethylidene)amino]pentanamide
- ethyl 2-(1,3-dimethyl-2-oxidanylidene-purin-6-yl)sulfanylethanoate
- (4R)-4-[(3R,5R,8R,9S,10S,12S,13R,14S,17R)-10,13-dimethyl-3,12-bis(oxidanyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-N-[(E)-(4-methoxyphenyl)methylideneamino]pentanamide
- ethyl 2-(1,3-dimethyl-2-oxidanylidene-6-sulfanylidene-purin-7-yl)ethanoate
- (4R)-4-[(3R,5R,8R,9S,10S,12S,13R,14S,17R)-10,13-dimethyl-3,12-bis(oxidanyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-N-[(E)-(4-methylphenyl)methylideneamino]pentanamide
- (4R)-4-[(3R,5R,8R,9S,10S,12S,13R,14S,17R)-10,13-dimethyl-3,12-bis(oxidanyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-N-[(E)-(4-nitrophenyl)methylideneamino]pentanamide
